meddevicedb.com FDA Device Reference

HUMAN CHORIONIC GONADOTROPIN (HCG) TEST SYSTEM FOR THE EARLY DETECTION OF PREGNANCY

K950354 Class II Traditional
Decision Date
1995-07-19
Sponsor / Applicant
Ml Strategies, Inc.

Technical Specification

510(k) Submission ID K950354
Product Code LCX
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1155
Decision Date 1995-07-19
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

HUMAN CHORIONIC GONADOTROPIN (HCG) TEST SYSTEM FOR THE EARLY DETECTION OF PREGNANCY received FDA 510(k) clearance under submission number K950354, sponsored by Ml Strategies, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1995-07-19.

Classification & Regulation

This clearance is catalogued under FDA product code LCX and 21 CFR 862.1155, within the Clinical Chemistry review panel as a Class II device.